advance

Akston has reclaimed all commercial rights to AKS-452, its room temperature stable COVID-19 vaccine Akston is continuing its progress to secure Emergency Use Authorization (EUA) in India and has begun working with a new CDMO to produce…

New Modulator Increases Speed and Scale to 224G/λ for Future High-Speed Applications MOUNTAIN VIEW, Calif., March 6, 2023 /PRNewswire/ -- OpenLight today announced that it developed and successfully demonstrated a 224G InP-based modulator…

Industry powerhouses to guide work of new SEMI Supply Chain Management (SCM) Initiative MILPITAS, Calif., Feb. 28, 2023 /PRNewswire/ -- SEMI, the industry association serving the global electronics manufacturing and design supply chain,…

Springer Nature has entered into an exclusive partnership with BITS Pilani, a renowned institute offering higher education in the fields of science, engineering, pharmacy and management in India. The partnership will advance…

Novel compact, single-story 4 Kelvin 1.0 GHz NMR systems already accepted at RIKEN, Japan and University of Barcelona, Spain in late 2022 ahead of schedule FÄLLANDEN, Switzerland--(BUSINESS WIRE)--$BRKR #BRKR--Bruker today announced…

UAE's global clean energy powerhouse signs deals for projects with a combined generation capacity of 5 GW across Angola, Uganda, and ZambiaAgreements signed under umbrella of Etihad 7 – a global development fund launched by the UAE to…

Altair Units licensing system will provide access to full suite of Altair solutions TROY, Mich., Jan. 17, 2023 /PRNewswire/ -- Altair (Nasdaq: ALTR), a global leader in computational science and artificial intelligence (AI) announced that…

The genome database will power ongoing scientific efforts worldwide and help advance individualized pet health careInsights from this partnership will feed into the MARS PETCARE BIOBANK™, a longitudinal study to understand pet health and…

Presenting details on initial response data from the ongoing VITALIZE DLBCL trial at the Immuno-Oncology 360° conference on February 10, 2023 Expects preliminary clinical response data from the AVALON Phase 2b trial in H2 2023 Recently…

Mid-stage and Pivotal Trials of ANX005, ANX007 and ANX1502 Poised to Achieve Numerous Catalysts in Multiple Disease Indications Well-Capitalized with Operating Runway into 2025 Company to Present Pipeline Updates at 41st Annual J.P.…